Wall St set for $1bn fee bonanza from pharma mega-deal

Wall St set for $1bn fee bonanza from pharma mega-deal

bristol-myers squibb

Drugmakers Bristol-Myers Squibb and Celgene will pay about $1bn in fees to seal their $90bn tie-up, including more than $300m to their financial advisers, in one of the most lucrative advisory assignments ever recorded on Wall Street. The fees will be split among a handful of investment banks, including Morgan Stanley, JPMorgan Chase and Citigroup,…

This content is for Standard Bi-Annual, Premium Bi-Annual, Standard Yearly, Premium Yearly, Standard Yearly USD, Premium Yearly USD and BusinessDay/Ready Set Work Premium Yearly (FREE) members only. Visit the site and log in/register to read.
What do you think about this post?
We want to hear from you all.
CLICK TO SEE OR ADD COMMENT

LEAVE A REPLY

Please enter your comment!
Please enter your name here